D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 121 Citations 114,149 608 World Ranking 1502 National Ranking 142

Research.com Recognitions

Awards & Achievements

2015 - Fellow of the Australian Academy of Health and Medical Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Disease

Internal medicine, Blood pressure, Diabetes mellitus, Surgery and Type 2 diabetes are his primary areas of study. Internal medicine and Cardiology are commonly linked in his work. His work in Diabetes mellitus addresses subjects such as Proportional hazards model, which are connected to disciplines such as Diabetic angiopathy.

He interconnects Odds ratio, Hazard ratio, Confidence interval, Placebo-controlled study and Aspirin in the investigation of issues within Surgery. The Type 2 diabetes study which covers Nephropathy that intersects with Diabetic nephropathy. His studies in Relative risk integrate themes in fields like Meta-analysis and Risk factor.

His most cited work include:

  • A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 (7776 citations)
  • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (5527 citations)
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (4452 citations)

What are the main themes of his work throughout his whole career to date?

Bruce Neal focuses on Internal medicine, Blood pressure, Randomized controlled trial, Diabetes mellitus and Type 2 diabetes. Bruce Neal combines subjects such as Placebo, Canagliflozin and Cardiology with his study of Internal medicine. Bruce Neal has researched Blood pressure in several fields, including Salt substitute, Sodium, Intensive care medicine, Meta-analysis and Vascular disease.

His research integrates issues of Physical therapy, Clinical trial and Confidence interval in his study of Randomized controlled trial. His research in Diabetes mellitus intersects with topics in Body mass index and Disease. His Type 2 diabetes study incorporates themes from Relative risk, Nephropathy, Adverse effect, Hazard ratio and Albuminuria.

He most often published in these fields:

  • Internal medicine (63.93%)
  • Blood pressure (23.63%)
  • Randomized controlled trial (28.23%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (63.93%)
  • Canagliflozin (30.22%)
  • Type 2 diabetes (32.46%)

In recent papers he was focusing on the following fields of study:

Bruce Neal mostly deals with Internal medicine, Canagliflozin, Type 2 diabetes, Kidney disease and Diabetes mellitus. His study in Randomized controlled trial, Heart failure, Blood pressure, Meta-analysis and Hazard ratio is carried out as part of his Internal medicine studies. His work carried out in the field of Canagliflozin brings together such families of science as Post-hoc analysis, Placebo, Urology and Renal function.

Bruce Neal interconnects Relative risk, Confidence interval, Adverse effect, Proportional hazards model and Creatinine in the investigation of issues within Type 2 diabetes. His work in the fields of Kidney disease, such as Albuminuria, overlaps with other areas such as Quality-adjusted life year. His research in Diabetes mellitus is mostly concerned with Nephropathy.

Between 2019 and 2021, his most popular works were:

  • Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (401 citations)
  • The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. (88 citations)
  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study (83 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Disease

Bruce Neal spends much of his time researching Internal medicine, Canagliflozin, Type 2 diabetes, Kidney disease and Diabetes mellitus. His biological study spans a wide range of topics, including Creatinine and Proportional hazards model. Bruce Neal has included themes like Renal function, Relative risk, Adverse effect, Hematocrit and Placebo in his Type 2 diabetes study.

The concepts of his Relative risk study are interwoven with issues in Empagliflozin and Dapagliflozin. His Kidney disease research incorporates themes from Disease burden, Type 2 Diabetes Mellitus and Environmental health. The study incorporates disciplines such as Randomized controlled trial and Urology in addition to Diabetes mellitus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Anushka Patel;Stephen MacMahon;John Chalmers.
The New England Journal of Medicine (2008)

8711 Citations

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Stephen S. Lim;Theo Vos;Abraham D. Flaxman;Goodarz Danaei.
The Lancet (2012)

7776 Citations

1999 WORLD HEALTH ORGANIZATION-INTERNATIONAL SOCIETY OF HYPERTENSION GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION

M. Alderman;K. Arakawa;L. Beilin;J. Chalmers.
Journal of Hypertension (1999)

6038 Citations

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

Mohammad H Forouzanfar;Lily Alexander;H Ross Anderson;Victoria F Bachman.
The Lancet (2015)

5179 Citations

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

S. MacMahon;B. Neal;C. Tzourio;A. Rodgers.
The Lancet (2001)

4227 Citations

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw.
The New England Journal of Medicine (2017)

4139 Citations

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)

2786 Citations

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

B Neal;S MacMahon;N Chapman.
The Lancet (2000)

2391 Citations

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013 : a systematic analysis for the Global Burden of Disease Study 2013

Mohammad H. Forouzanfar;Lily Alexander;H. Ross Anderson;Victoria F. Bachman.
The Lancet (2015)

2119 Citations

Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015

Gregory A. Roth;Catherine Johnson;Amanuel Abajobir;Foad Abd-Allah.
Journal of the American College of Cardiology (2017)

2011 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Bruce Neal

Mark Woodward

Mark Woodward

George Institute for Global Health

Publications: 253

John Chalmers

John Chalmers

George Institute for Global Health

Publications: 227

Craig S. Anderson

Craig S. Anderson

George Institute for Global Health

Publications: 224

Giuseppe Mancia

Giuseppe Mancia

University of Milano-Bicocca

Publications: 223

Christopher J L Murray

Christopher J L Murray

University of Washington

Publications: 209

Andre Pascal Kengne

Andre Pascal Kengne

South African Medical Research Council

Publications: 162

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 159

Massimo Volpe

Massimo Volpe

Sapienza University of Rome

Publications: 154

Vivekanand Jha

Vivekanand Jha

George Institute for Global Health

Publications: 153

Mohsen Naghavi

Mohsen Naghavi

University of Washington

Publications: 151

Theo Vos

Theo Vos

University of Washington

Publications: 148

Ali H. Mokdad

Ali H. Mokdad

University of Washington

Publications: 147

Hiddo J.L. Heerspink

Hiddo J.L. Heerspink

George Institute for Global Health

Publications: 146

Alan D. Lopez

Alan D. Lopez

University of Melbourne

Publications: 142

Kamlesh Khunti

Kamlesh Khunti

University of Leicester

Publications: 139

Jürgen Rehm

Jürgen Rehm

Centre for Addiction and Mental Health

Publications: 138

Something went wrong. Please try again later.